These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 29265831)

  • 1. Prevention of relapse/recurrence in major depressive disorder with either mindfulness-based cognitive therapy or cognitive therapy.
    Farb N; Anderson A; Ravindran A; Hawley L; Irving J; Mancuso E; Gulamani T; Williams G; Ferguson A; Segal ZV
    J Consult Clin Psychol; 2018 Feb; 86(2):200-204. PubMed ID: 29265831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse/Recurrence Prevention in Major Depressive Disorder: 26-Month Follow-Up of Mindfulness-Based Cognitive Therapy Versus an Active Control.
    Shallcross AJ; Willroth EC; Fisher A; Dimidjian S; Gross JJ; Visvanathan PD; Mauss IB
    Behav Ther; 2018 Sep; 49(5):836-849. PubMed ID: 30146148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice of therapy acquired regulatory skills and depressive relapse/recurrence prophylaxis following cognitive therapy or mindfulness based cognitive therapy.
    Segal ZV; Anderson AK; Gulamani T; Dinh Williams LA; Desormeau P; Ferguson A; Walsh K; Farb NAS
    J Consult Clin Psychol; 2019 Feb; 87(2):161-170. PubMed ID: 30431297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.
    Segal ZV; Bieling P; Young T; MacQueen G; Cooke R; Martin L; Bloch R; Levitan RD
    Arch Gen Psychiatry; 2010 Dec; 67(12):1256-64. PubMed ID: 21135325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Morant N; Taylor RS; Byford S
    Health Technol Assess; 2015 Sep; 19(73):1-124. PubMed ID: 26379122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial.
    Huijbers MJ; Spinhoven P; Spijker J; Ruhé HG; van Schaik DJ; van Oppen P; Nolen WA; Ormel J; Kuyken W; van der Wilt GJ; Blom MB; Schene AH; Donders AR; Speckens AE
    J Affect Disord; 2015 Nov; 187():54-61. PubMed ID: 26318271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between decentering and reductions in relapse/recurrence in mindfulness-based cognitive therapy for depression in adults: A randomized controlled trial.
    Moore MT; Lau MA; Haigh EAP; Willett BR; Bosma CM; Fresco DM
    J Consult Clin Psychol; 2022 Feb; 90(2):137-147. PubMed ID: 35343725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of CBT and its modifications for relapse prevention in major depressive disorder: a systematic review and meta-analysis.
    Zhang Z; Zhang L; Zhang G; Jin J; Zheng Z
    BMC Psychiatry; 2018 Feb; 18(1):50. PubMed ID: 29475431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse prevention in major depressive disorder: Mindfulness-based cognitive therapy versus an active control condition.
    Shallcross AJ; Gross JJ; Visvanathan PD; Kumar N; Palfrey A; Ford BQ; Dimidjian S; Shirk S; Holm-Denoma J; Goode KM; Cox E; Chaplin W; Mauss IB
    J Consult Clin Psychol; 2015 Oct; 83(5):964-75. PubMed ID: 26371618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with a preference for medication do equally well in mindfulness-based cognitive therapy for recurrent depression as those preferring mindfulness.
    Huijbers MJ; Spinhoven P; van Schaik DJ; Nolen WA; Speckens AE
    J Affect Disord; 2016 May; 195():32-9. PubMed ID: 26852095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial.
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Brejcha C; Cardy J; Causley A; Cowderoy S; Evans A; Gradinger F; Kaur S; Lanham P; Morant N; Richards J; Shah P; Sutton H; Vicary R; Weaver A; Wilks J; Williams M; Taylor RS; Byford S
    Lancet; 2015 Jul; 386(9988):63-73. PubMed ID: 25907157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Utility Analysis of Mindfulness-Based Cognitive Therapy Versus Antidepressant Pharmacotherapy for Prevention of Depressive Relapse in a Canadian Context: Analyse coût-utilité de la thérapie cognitive basée sur la pleine conscience contre la pharmacothérapie antidépressive pour prévenir la rechute de la dépression en contexte canadien.
    Pahlevan T; Ung C; Segal Z
    Can J Psychiatry; 2020 Aug; 65(8):568-576. PubMed ID: 32031000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
    Teasdale JD; Segal ZV; Williams JM; Ridgeway VA; Soulsby JM; Lau MA
    J Consult Clin Psychol; 2000 Aug; 68(4):615-23. PubMed ID: 10965637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update to the study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment depressive relapse/recurrence: the PREVENT trial.
    Kuyken W; Byford S; Byng R; Dalgleish T; Lewis G; Taylor R; Watkins ER; Hayes R; Lanham P; Kessler D; Morant N; Evans A
    Trials; 2014 Jun; 15():217. PubMed ID: 24916319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mindfulness-based cognitive therapy for recurrent depression: A translational research study with 2-year follow-up.
    Meadows GN; Shawyer F; Enticott JC; Graham AL; Judd F; Martin PR; Piterman L; Segal Z
    Aust N Z J Psychiatry; 2014 Aug; 48(8):743-55. PubMed ID: 24595511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mindfulness-based cognitive therapy for residual depressive symptoms and relapse prophylaxis.
    Segal ZV; Walsh KM
    Curr Opin Psychiatry; 2016 Jan; 29(1):7-12. PubMed ID: 26575299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive reactivity as outcome and working mechanism of mindfulness-based cognitive therapy for recurrently depressed patients in remission.
    Cladder-Micus MB; van Aalderen J; Donders ART; Spijker J; Vrijsen JN; Speckens AEM
    Cogn Emot; 2018 Mar; 32(2):371-378. PubMed ID: 28278742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does mindfulness-based cognitive therapy with tapering support reduce risk of relapse/recurrence in major depressive disorder by enhancing positive affect? A secondary analysis of the PREVENT trial.
    Dunn BD; Warbrick L; Hayes R; Montero-Marin J; Reed N; Dalgleish T; Kuyken W
    J Consult Clin Psychol; 2024 Sep; 92(9):619-629. PubMed ID: 39418459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol.
    Cladder-Micus MB; Vrijsen JN; Becker ES; Donders R; Spijker J; Speckens AE
    BMC Psychiatry; 2015 Nov; 15():275. PubMed ID: 26553106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-specific changes in decentering following mindfulness-based cognitive therapy versus antidepressant medication or placebo for prevention of depressive relapse.
    Bieling PJ; Hawley LL; Bloch RT; Corcoran KM; Levitan RD; Young LT; Macqueen GM; Segal ZV
    J Consult Clin Psychol; 2012 Jun; 80(3):365-72. PubMed ID: 22409641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.